Evolution of the atrial fibrillation substrate in experimental congestive heart failure: Angiotensin-dependent and -independent pathways

Cardiovascular Research

Volumn 60, Issue 2, 2003, Pages 315-325

  Cardin, Sophie ^a,b   Li, Danshi ^a,c   Thorin Trescases, Nathalie ^a   Leung, Tack Ki ^a,c   Thorin, Eric ^a,c   Nattel, Stanley ^a,b,c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Arrhythmia therapy; Atrial fibrillation; Remodelling

Indexed keywords

ANGIOTENSIN; CASPASE 3; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA FRAGMENT; ENALAPRIL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN JNK; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL INFILTRATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; ENZYMATIC ASSAY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART MUSCLE FIBROSIS; HEART VENTRICLE PACING; HISTOPATHOLOGY; LEUKOCYTE; MYOCARDITIS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; APOPTOSIS; ATRIAL FIBRILLATION; BCL-2-ASSOCIATED X PROTEIN; BIOLOGICAL MARKERS; CARDIAC PACING, ARTIFICIAL; CASPASE 3; CASPASES; DNA FRAGMENTATION; DOGS; ENALAPRIL; HEART ATRIA; HEART FAILURE, CONGESTIVE; IN SITU NICK-END LABELING; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0242459007     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2003.08.014     Document Type: Article

References (33)

1. Aimé-Sempé C., Folliguet T., Rucker-Martin C.et al. Myocardial cell death in fibrillating and dilated human right atria. J. Am. Coll. Cardiol. 34:1999;1577-1586.
2. Narula J., Haider N., Virmani R.et al. Apoptosis in myocytes in end-stage heart failure. N. Engl. J. Med. 335:1996;1182-1189.
3. Sharov V.G., Sabbah H.N., Shimoyama H., Goussev A.V., Lesch M., Goldstein S. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am. J. Pathol. 148:1996;141-149.
4. Allessie M.A., Boyden P.A., Camm A.J.et al. Pathophysiology and prevention of atrial fibrillation. Circulation. 103:2001;769-777.
5. Dispersyn G.D., Ausma J., Thone F.et al. Cardiomyocyte remodelling during myocardial hibernation and atrial fibrillation: prelude to apoptosis. Cardiovasc. Res. 43:1999;947-957.
6. Li D., Fareh S., Leung T.K., Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation. 100:1999;87-95.
7. Lie J.T., Falk R.H., James T.M. Cardiac anatomy and pathologic correlates of atrial fibrillation. Falk R.H., Podrid P.J. Atrial fibrillation - mechanisms and management. 1997;23-52 Lippincott-Raven, Philadelphia.
8. Li D., Shinagawa K., Pang L.et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation. 104:2001;2608-2614.
9. Kajstura J., Cigola E., Malhotra A.et al. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J. Mol. Cell. Cardiol. 29:1997;859-870.
10. Yano M., Kim S., Izumi Y., Yamanaka S., Iwao H. Differential activation of cardiac c-jun amino-terminal kinase and extracellular signal-regulated kinase in angiotensin II-mediated hypertension. Circ. Res. 83:1998;752-760.
11. van Eickels M., Grohe C., Lobbert K., Stimpel M., Vetter H. Angiotensin-converting enzyme inhibitors block mitogenic signalling pathways in rat cardiac fibroblasts. Naunyn-Schmiedeberg's Arch. Pharmacol. 359:1999;394-399.
12. Cesselli D., Jakoniuk I., Barlucchi L.et al. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ. Res. 89:2001;279-286.
13. Heinke M.Y., Yao M., Chang D., Einstein R., dos Remedios C.G. Apoptosis of ventricular and atrial myocytes from pacing-induced canine heart failure. Cardiovasc. Res. 49:2001;127-134.
14. Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo M.A., Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 96:1997;1180-1184.
15. Everett T.H. IV, Li H., Mangrum J.M.et al. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation. Circulation. 102:2000;1454-1460.
16. Henson P.M., Bratton D.L., Fadok V.A. Apoptotic cell removal. Curr. Biol. 11:2001;R795-R805.
17. Yang B., Johnson T.S., Thomas G.L., Watson P.F., Wagner B., Nahas A.M. Apoptosis and caspase-3 in experimental anti-glomerular basement membrane nephritis. J. Am. Soc. Nephrol. 12:2001;485-495.
18. Miyajima A., Chen J., Lawrence C.et al. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int. 58:2000;2301-2313.
19. Shi Y., Ducharme A., Li D., Gaspo R., Nattel S., Tardif J.C. Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation. Cardiovasc. Res. 52:2001;217-225.
20. Barlucchi L., Leri A., Dostal D.E.et al. Canine ventricular myocytes possess a renin-angiotensin system that is upregulated with heart failure. Circ. Res. 88:2001;298-304.
21. Lapointe N., Rouleau J.L. Activation of vascular tissue angiotensin-converting enzyme (ACE) in heart failure. Effects of ACE inhibitors. J. Am. Coll. Cardiol. 39:2002;776-779.
22. Goette A., Staack T., Rocken C.et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J. Am. Coll. Cardiol. 35:2000;1669-1677.
23. Goette A., Arndt M., Rocken C.et al. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation. 101:2000;2678-2681.
24. Pedersen O.D., Bagger H., Kober L., Torp-Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation. 100:1999;376-380.
25. Zou Y., Komuro I., Yamazaki T.et al. Cell type-specific angiotensin II-evoked signal transduction pathways: critical roles of Gbetagamma subunit, Src Family, and Ras in cardiac fibroblasts. Circ. Res. 82:1998;337-345.
26. Chung M.K., Martin D.O., Sprecher D.et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 104:2001;2886-2891.
27. Mihm M.J., Yu F., Carnes C.A., Reiser P.J., McCarthy P.M., Van Wagoner D.R.et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation. 104:2001;174-180.
28. Kumagai K., Nakashima H., Urata H., Gondo N., Arakawa K., Saku K. Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J. Am. Coll. Cardiol. 41:2003;2197-2204.
29. Ihara M., Urata H., Shirai K., Ideishi M., Hoshino F., Suzumiya J.et al. High cardiac angiotensin-II-forming activity in infarcted and non-infarcted human myocardium. Cardiology. 94:2000;247-253.
30. Lindstedt K.A., Wang Y., Shiota N., Saarinen J., Hyytiainen M., Kokkonen J.O.et al. Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase. FASEB J. 15:2001;1377-1388.
31. Matsumoto T., Wada A., Tsutamoto T., Ohnishi M., Isono T., Kinoshita M. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Circulation. 107:2003;2555-2558.
32. Goette A., Arndt M., Rocken C., Staack T., Bechtloff R., Reinhold D.et al. Calpains and cytokines in fibrillating human atria. Am. J. Physiol., Heart Circ. Physiol. 283:2002;H264-H272.
33. Minamino T., Yujiri T., Papst P.J., Chan E.D., Johnson G.L., Terada N. MEKK1 suppresses oxidative stress-induced apoptosis of embryonic stem cell-derived cardiac myocytes. Proc. Natl. Acad. Sci. U.S.A. 96:1999;15127-15132.